AN2 Therapeutics, Inc. (ANTX) ownership: Top institutional holder: Vivo Capital, LLC ($10.79M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Vivo Capital, LLC | 3153640.00 | $10.79M | 2026-03-31 |
| Commodore Capital LP | 2333713.00 | $7.98M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 2222502.00 | $7.60M | 2026-03-31 |
| Spruce Street Capital LP | 1661073.00 | $5.58M | 2026-03-31 |
| Almitas Capital LLC | 1479129.00 | $5.06M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1011078.00 | $3.46M | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1000000.00 | $3.42M | 2026-03-31 |
| Woodline Partners LP | 993671.00 | $3.40M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-07-10 | |
| Sell | null | 2026-07-10 | |
| Sell | null | 2026-07-10 | |
| Sell | null | 2026-07-08 | |
| Sell | null | 2026-05-29 |
Back to ANTX overview · ANTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.